GB1333905A - Method for o-acylating 7-acylaminocephalosporadesic acids and o-acyl-7-acylaminocephalosporadesic acids - Google Patents

Method for o-acylating 7-acylaminocephalosporadesic acids and o-acyl-7-acylaminocephalosporadesic acids

Info

Publication number
GB1333905A
GB1333905A GB1634272A GB1634272A GB1333905A GB 1333905 A GB1333905 A GB 1333905A GB 1634272 A GB1634272 A GB 1634272A GB 1634272 A GB1634272 A GB 1634272A GB 1333905 A GB1333905 A GB 1333905A
Authority
GB
United Kingdom
Prior art keywords
acyl
reaction
acid
azolide
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1634272A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Priority to US255632A priority Critical patent/US3905967A/en
Publication of GB1333905A publication Critical patent/GB1333905A/en
Priority to US05/577,816 priority patent/US4007178A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

1333905 O-Acylating 3-hydroxymethylcephalosporins; D-mandelic acid derivatives SMITH KLINE & FRENCH LABORATORIES 10 April 1972 [7 May 1971] 16342/72 Headings C2A and C2C 3 - Acyloxymethyl - 7 - acylaminocephalosporanic acids are prepared by acylating the 3-hydroxymethyl group of a 3-deacetyl-7-acylaminocephalosporanic acid by reaction with an azolide, any hydroxy, amino or thiol groups in the N-acyl group of the azolide being suitably protected during the acylation and the protecting groups being removed thereafter. The azolide is defined as an N-acyl heterocyclic compound wherein the heterocycle is a quasiaromatic 5-membered ring containing at least two nitrogen atoms, e.g. l-acyl-1,2,4-triazole or 1-acyl-1,2,3-triazole. It is prepared in situ by reacting a carboxylic acid with a diazolide of carbonic acid (N,N<SP>1</SP>-carbonyldiimidazole) in a reaction-inert solvent according to the reaction: The 3-deacetylcephalosporin, preferably as an alkali metal salt, is then added to the reaction mixture, when the following reaction takes place. In the formulµ above, is an acyl group found in the 7-acylamino group of a known antibacterial cephalosporin, is the same as except that any hydroxy, amino and carboxy groups have protecting groups, is an acyl group found in the 3-acyloxymethyl group of a known antibacterial cephalosporin except that an easily eliminated #-substituent may not be present, is the same as except that any hydroxy, amino and thiol groups have protecting groups, and -N# is a quasiaromatic five-membered ring. The process is preferably carried out at neutral to mildly basic pH in a reaction-inert solvent (e.g. benzene, tetrahydrofuran, chloroform or dimethyl-formamide) at 0-50‹ C. o - (2,2,2 - Trichloroethoxycarbonyl)- D - mandelic acid is prepared by reacting D-mandelic acid with 2,2,2-trichloroethyl chloroformate in the presence of N,N-dimethylaniline, and is subsequently converted to the acid chloride with thionyl chloride.
GB1634272A 1971-05-07 1972-04-10 Method for o-acylating 7-acylaminocephalosporadesic acids and o-acyl-7-acylaminocephalosporadesic acids Expired GB1333905A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US255632A US3905967A (en) 1971-05-07 1972-05-22 Method for O-acylating 7-acylamino-cephalosporadesic acids
US05/577,816 US4007178A (en) 1972-04-10 1975-05-15 O-acyl-7-acylaminocephalosporadesic acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14138071A 1971-05-07 1971-05-07

Publications (1)

Publication Number Publication Date
GB1333905A true GB1333905A (en) 1973-10-17

Family

ID=22495444

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1634272A Expired GB1333905A (en) 1971-05-07 1972-04-10 Method for o-acylating 7-acylaminocephalosporadesic acids and o-acyl-7-acylaminocephalosporadesic acids

Country Status (7)

Country Link
AU (1) AU458987B2 (en)
BE (1) BE783095A (en)
CA (1) CA999291A (en)
DE (1) DE2222200A1 (en)
FR (1) FR2137569B1 (en)
GB (1) GB1333905A (en)
ZA (1) ZA723060B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987005297A1 (en) * 1986-03-03 1987-09-11 The University Of Chicago Cephalosporin derivatives

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987005297A1 (en) * 1986-03-03 1987-09-11 The University Of Chicago Cephalosporin derivatives
US4783443A (en) * 1986-03-03 1988-11-08 The University Of Chicago Amino acyl cephalosporin derivatives

Also Published As

Publication number Publication date
ZA723060B (en) 1973-02-28
FR2137569A1 (en) 1972-12-29
FR2137569B1 (en) 1975-10-31
DE2222200A1 (en) 1972-11-16
BE783095A (en) 1972-11-06
CA999291A (en) 1976-11-02
AU458987B2 (en) 1975-03-13
AU4190972A (en) 1973-11-08

Similar Documents

Publication Publication Date Title
GB1470188A (en) Penicillins
ES452361A1 (en) Process for manufacture of 9-amino-9-deoxyclavulanates
ES403305A1 (en) Cephalosporins
GB1535215A (en) Kanamycin derivatives
GB1333905A (en) Method for o-acylating 7-acylaminocephalosporadesic acids and o-acyl-7-acylaminocephalosporadesic acids
PL88515B1 (en)
ES471770A1 (en) Cephalosporins and penicillins, processes for their preparation and pharmaceutical compositions containing them.
US3647787A (en) Process improvement for converting penicillin sulfoxide esters to cephem compounds
GB1017624A (en) Cephalosporin compounds
ES427901A1 (en) Substituted beta-lactams and their preparation
ES451053A1 (en) Process for producing penicillins and cephalosporins
GB894460A (en) Improvements in or relating to penicillins
GB1081093A (en) Improvements in or relating to 6-[d(-)-alpha-(amino-phenylacetamido)]-penicillanic acid derivatives
GB1512660A (en) Cephalosporin esters
ES424204A1 (en) 1-oxadethiapenicillanic acid derivatives
GB1211694A (en) Derivatives of 7-aminocephalosporanic acid
GB1329590A (en) Amino-oxy carboxylic acid amides
JPS5620587A (en) Beta-lactam antibiotic
GB1430238A (en) Esters
ES2002912A6 (en) Acetic acid thioesters as starting materials for cephalosporins
SU443036A1 (en) The method of obtaining aromatic and heterocyclic derivatives of simmtriazine
GB891777A (en) Improvements in or relating to substances produced from penicillin-producing moulds
ES452779A1 (en) 7-(alpha-(2-oxo-imidazolidin-1-yl-carbonylamino)-phenylacetamido)-cephalosporins processes for their preparation and their use as medicaments
GB1030759A (en) Penicillins
GB1538284A (en) 2-oxo-imidazolidine(-yl-carbonyl or thiocarbonylamino)-acetamido penicillins and cephalosporins

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee